|
⚲
|
| Keyboard |
| John Hadden II | |
|---|---|
| Firm | |
| Address | 25E 86th Street Apt 3D New York, NY 10028 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Virocell Biologics Ltd | 021-464890 | Executive Officer | 1.0 M of 2.3 M |
||
| PLX Pharma Inc | 021-381708 | Director | 18.0 M of 18.0 M |
||
| PLX Pharma Inc | 021-367889 | Director | 8.0 M of 8.0 M |
||
| PLX Pharma Inc | 021-333941 | Director | 15.0 M of 15.0 M |
||
| IRX Therapeutics Inc | 021-278212 | Executive Officer | 33.2 M of 33.2 M |
||
| IRX Therapeutics Inc | 021-274149 | Executive Officer | 6.4 M of 8.0 M |
||
| IRX Therapeutics Inc | 021-263122 | Executive Officer | 2.0 M of 15.0 M |
||
| PLX Pharma Inc | 021-259059 | Director | 1.3 M of 2.0 M |
||
| IRX Therapeutics Inc | 021-232269 | Executive Officer | 40.6 M of 40.6 M |
||
| IRX Therapeutics Inc | 021-213624 | Executive Officer | 15.1 M of 18.0 M |
||
| IRX Therapeutics Inc | 021-178994 | Executive Officer | 1.5 M of 1.5 M |
||
| IRX Therapeutics Inc | 021-143398 | Executive Officer | 8.0 M | ||